Follow-up labs every 3 months are advised
GLP-1 receptor agonists (GLP-1 RAs), which regulate glucose metabolism through mechanisms such as enhancing glucose-dependent insulin secretion via the incretin effect, suppressing glucagon secretion, delaying gastric emptying, and supporting pancreatic -cell proliferation, are primarily used in the management of type 2 diabetes mellitus (T2DM) and, in certain cases, obesity [23]
The decline of estrogen and progesterone withdraws hormonal signals that had been governing cellular energy regulation, mitochondrial function, and inflammatory tone across the brain, vasculature, adipose tissue, and skeletal muscle simultaneously
Garcia, J
In clinical trials, tirzepatide has produced weight loss results comparable to or exceeding semaglutide
CAS Number: 901758-09-6